Cai‐Fang Ni
About
Cai‐Fang Ni is a scholar working on Hepatology, Surgery and Epidemiology.
According to data from OpenAlex, Cai‐Fang Ni has authored 45 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hepatology, 16 papers in Surgery and 14 papers in Epidemiology. Recurrent topics in Cai‐Fang Ni's work include Hepatocellular Carcinoma Treatment and Prognosis (31 papers), Liver Disease and Transplantation (15 papers) and Liver Disease Diagnosis and Treatment (11 papers). Cai‐Fang Ni is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (31 papers), Liver Disease and Transplantation (15 papers) and Liver Disease Diagnosis and Treatment (11 papers). Cai‐Fang Ni collaborates with scholars based in China, United States and Canada. Cai‐Fang Ni's co-authors include Bin‐Yan Zhong, Wansheng Wang, Wei Li, Xiaoli Zhu, Jian Shen, Hai‐Dong Zhu, Xiaoli Zhu, Jiansong Ji, Peng Huang and Gao‐Jun Teng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Radiology and Journal of Hepatology.
In The Last Decade
Cai‐Fang Ni
42 papers receiving 468 citations
Peers
Cai‐Fang Ni
Claus Kölblinger Austria
Eleonora Terzi Italy
Zhi Qin Gao China
Lianghe Lu China
Ling Huo China
Philippe Porée France
Chen‐Chun Lin Taiwan
Sudeep Banerjee India
Vlasios S. Sotirchos United States
Mengxuan Zuo China
Citations per year, relative to Cai‐Fang Ni Cai‐Fang Ni (= 1×)
peers
Claus Kölblinger
Countries citing papers authored by Cai‐Fang Ni
Since
Specialization
Citations
This map shows the geographic impact of Cai‐Fang Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cai‐Fang Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cai‐Fang Ni more than expected).
Fields of papers citing papers by Cai‐Fang Ni
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Cai‐Fang Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cai‐Fang Ni. The network helps show where Cai‐Fang Ni may publish in the future.
Co-authorship network of co-authors of Cai‐Fang Ni
This figure shows the co-authorship network connecting the top 25 collaborators of Cai‐Fang Ni. A scholar is included among the top collaborators of Cai‐Fang Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cai‐Fang Ni. Cai‐Fang Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Wang, Meiling, et al.. (2024). Manganese improves CD8+ T cell recruitment via cGAS-STING in hepatocellular carcinoma. International Immunopharmacology. 143(Pt 3). 113591–113591.
2.
Qu, Weiwei, Dong Zhang, Bin‐Yan Zhong, et al.. (2024). Evaluation of Radiation Exposure and Influential Factors in Cone-Beam Computed Tomography (CBCT) of the Head and Abdomen during Interventional Procedures. Tomography. 10(3). 320–330.
3.
Huang, Jintao, Bin‐Yan Zhong, Junhui Sun, et al.. (2023). Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma with Child-Pugh B7. Journal of Hepatocellular Carcinoma. Volume 10. 1629–1638.
4.
Chen, Li, et al.. (2023). Modified quantitative and volumetric response evaluation criteria for patients with hepatocellular carcinoma after transarterial chemoembolization. Frontiers in Oncology. 13. 957722–957722.
5.
Jiang, Nan, Bin‐Yan Zhong, Jintao Huang, et al.. (2023). Transarterial chemoembolization combined with molecularly targeted agents plus immune checkpoint inhibitors for unresectable hepatocellular carcinoma: a retrospective cohort study. Frontiers in Immunology. 14. 1205636–1205636.
6.
Zhang, Shen, Bin‐Yan Zhong, Lei Zhang, Wansheng Wang, & Cai‐Fang Ni. (2022). Transarterial chemoembolization failure/refractoriness: A scientific concept or pseudo-proposition. World Journal of Gastrointestinal Surgery. 14(6). 528–537.
7.
Jin, Zhi‐Cheng, Li Chen, Bin‐Yan Zhong, et al.. (2021). Machine-learning analysis of contrast-enhanced computed tomography radiomics predicts patients with hepatocellular carcinoma who are unsuitable for initial transarterial chemoembolization monotherapy: A multicenter study. Translational Oncology. 14(4). 101034–101034.
8.
Zhao, Suming, Liwei Qiu, Hui Zhao, et al.. (2021). Prognostic nomogram for hepatocellular carcinoma patients after transarterial chemoembolization based on des-γ-carboxy prothrombin reactivity and modified Response Evaluation Criteria in Solid Tumors. Journal of Cancer Research and Therapeutics. 17(3). 707–714.
9.
Jin, Zhi‐Cheng, Li Chen, Bin‐Yan Zhong, et al.. (2021). Impact of COVID-19 Pandemic on Intervals and Outcomes of Repeated Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma. Frontiers in Oncology. 11. 602700–602700.
10.
Yan, Xinxin, et al.. (2021). A large-scale investigation by ultrasound of fetal hepatic venous system variants in China. Medical Ultrasonography. 24(2). 160–160.
11.
Zhong, Bin‐Yan, Zhiping Yan, Junhui Sun, et al.. (2021). Random Survival Forests to Predict Disease Control for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib. Frontiers in Molecular Biosciences. 8. 618050–618050.
12.
Zhong, Bin‐Yan, Wansheng Wang, Jian Shen, et al.. (2021). Single-Centre Retrospective Training Cohort Using Artificial Intelligence for Prognostic Prediction of Encephalopathy, Mortality, and Liver Dysfunction after Early TIPS Creation. CardioVascular and Interventional Radiology. 44(10). 1597–1608.
13.
Zhang, Lei, Zhiping Yan, Peng Huang, et al.. (2021). Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib. Frontiers in Molecular Biosciences. 8. 624366–624366.
14.
Zhang, Lei, Bin‐Yan Zhong, Wei Li, et al.. (2020). Stratification of portal vein-invaded hepatocellular carcinoma treated with transarterial chemoembolization monotherapy. SHILAP Revista de lepidopterología. 3(4). 201–207.
15.
Meng, Xiangpan, Yuancheng Wang, Shenghong Ju, et al.. (2020). Radiomics Analysis on Multiphase Contrast-Enhanced CT: A Survival Prediction Tool in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Frontiers in Oncology. 10. 1196–1196.
16.
Zhong, Bin‐Yan, Cai‐Fang Ni, Jiansong Ji, et al.. (2019). Nomogram and Artificial Neural Network for Prognostic Performance on the Albumin-Bilirubin Grade for Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Journal of Vascular and Interventional Radiology. 30(3). 330–338.
17.
Wang, Wansheng, et al.. (2019). Safety and Feasibility of Helical I-125 Seed Implants Combined with Transcatheter Arterial Chemoembolization in Hepatocellular Carcinomas with Main Portal Vein Tumor Thrombus. CardioVascular and Interventional Radiology. 42(10). 1420–1428.
18.
Wang, Chen, et al.. (2018). Feasibility of Helical I-125 Seed Implant in the Portal Vein. CardioVascular and Interventional Radiology. 42(1). 121–129.
19.
Wang, Kai, Guomin Jiang, Zhongzhi Jia, Xiaoli Zhu, & Cai‐Fang Ni. (2018). Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative. Medicine. 97(22). e10940–e10940.
20.
Shen, Jian, Wansheng Wang, Xiaoli Zhu, & Cai‐Fang Ni. (2018). High Epithelial Cell Adhesion Molecule–Positive Circulating Tumor Cell Count Predicts Poor Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization. Journal of Vascular and Interventional Radiology. 29(12). 1678–1684.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Claus Kölblinger Breakdown of academic impact, for papers by Eleonora Terzi Breakdown of academic impact, for papers by Zhi Qin Gao Breakdown of academic impact, for papers by Lianghe Lu Breakdown of academic impact, for papers by Ling Huo Breakdown of academic impact, for papers by Philippe Porée Breakdown of academic impact, for papers by Chen‐Chun Lin Breakdown of academic impact, for papers by Sudeep Banerjee Breakdown of academic impact, for papers by Vlasios S. Sotirchos Breakdown of academic impact, for papers by Mengxuan Zuo